New drug trial aims to shrink bulging eyes in thyroid disease
NCT ID NCT07257185
Summary
This study is testing whether a new injection called MHB018A can safely reduce eye bulging and other symptoms in people with long-term, moderate-to-severe Thyroid Eye Disease. About 150 participants will receive either the real injection or a placebo dummy shot every four weeks for six months. The main goal is to see if the treatment can significantly reduce eye bulging by week 24 compared to the placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID EYE DISEASE (TED) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 201419, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.